Clinigen Group ROA 2024

Clinigen Group Aktienanalyse

What does Clinigen Group do?

The Clinigen Group PLC is a global pharmaceutical company specializing in the provision of rare disease and hard-to-treat disease treatments. The company was founded in 2010 with the aim of quickly and efficiently providing access to life-saving medicines for patients. However, the history of Clinigen Group goes back further. The company has its roots in Besse Medical, an American drug distributor. In 2004, Clinigen acquired Besse Medical, followed by six more distributors in the US and Europe in the following years. These acquisitions formed the foundation for the current business model. The Clinigen Group's business model is based on three pillars. The first pillar is the "Clinigen Specialty Pharmaceuticals" sector, where the company manufactures and distributes life-saving drugs for severely ill patients worldwide. The second pillar is the "Unlicensed Medicines" business, which allows patients access to unlicensed medicines that are urgently needed in specific cases. Clinigen works with pharmaceutical companies and regulatory authorities to provide these medicines within a certain framework. The third pillar is the "Clinical Trials Supply" department, which supports and streamlines clinical studies by providing medicines and services. Overall, Clinigen offers a variety of products and services, all aimed at securing access to life-saving medicines for patients. These include drugs for the treatment of cancer, infections, autoimmune diseases, neurological diseases, and rare diseases. In addition, Clinigen also offers specialized logistics and distribution services to ensure that medicines reach patients quickly and efficiently. Today, Clinigen Group is a global company headquartered in the UK with offices in North America, Europe, and Asia. The company employs over 1,000 people and works with a variety of pharmaceutical companies and regulatory authorities. An important focus is on the development of new treatment options and therapies for rare and hard-to-treat diseases. Overall, Clinigen Group has established itself as an important player in the pharmaceutical and healthcare industry. The company offers a unique business model and a wide range of products and services to secure access to life-saving medicines for patients worldwide. With its focus on innovation and collaboration with other companies and authorities, Clinigen is committed to ensuring that patients receive quick and efficient access to the medicines they need. Clinigen Group ist eines der beliebtesten Unternehmen auf Eulerpool.com.

ROA Details

Understanding Clinigen Group's Return on Assets (ROA)

Clinigen Group's Return on Assets (ROA) is a key performance indicator that measures the company's profitability in relation to its total assets. It is calculated by dividing the net income by the total assets. A higher ROA indicates efficient asset utilization to generate profits, reflecting managerial effectiveness and financial health.

Year-to-Year Comparison

Comparing Clinigen Group's ROA year-over-year provides insights into the company’s operational efficiency and asset utilization trends. An increasing ROA demonstrates enhanced asset efficiency and profitability, while a declining ROA can indicate operational or financial challenges.

Impact on Investments

Investors consider Clinigen Group's ROA as a crucial metric to evaluate the company’s profitability and efficiency. A higher ROA signifies that the company is effectively utilizing its assets to generate profits, making it a potentially attractive investment.

Interpreting ROA Fluctuations

Variations in Clinigen Group’s ROA can be attributed to changes in net income, asset purchases, or operational efficiencies. Analyzing these fluctuations assists in assessing the company's financial performance, management efficiency, and strategic financial positioning.

Frequently Asked Questions about Clinigen Group Stock

What is the Return on Assets (ROA) of Clinigen Group this year?

The Return on Assets (ROA) of Clinigen Group is 0.03 undefined this year.

What was the ROA of Clinigen Group compared to the previous year?

The ROA of Clinigen Group has increased by 0% compared to the previous year.

What consequences do high ROA have for investors of Clinigen Group?

A high ROA is advantageous for investors of Clinigen Group, as it indicates that the company efficiently utilizes its assets and generates good profits.

What are the consequences of low ROA for investors in Clinigen Group?

A low ROA can be unfavorable for investors of Clinigen Group as it indicates that the company is inefficiently utilizing its assets and may potentially achieve lower profits.

How does an increase in the ROA of Clinigen Group affect the company?

An increase in ROA of Clinigen Group can be an indicator of improved efficiency in asset utilization and higher profitability.

How does a reduction in ROA of Clinigen Group impact the company?

A reduction in the ROA of Clinigen Group can be an indicator of lower asset efficiency and profitability.

What are some factors that can influence the ROA of Clinigen Group?

Some factors that can influence the ROA of Clinigen Group include revenue, operating costs, asset structure, and industry average.

Why is the ROA of Clinigen Group important for investors?

The ROA of Clinigen Group is important for investors as it is an indicator of the company's profitability and efficiency in utilizing assets. It provides investors with information on how well the company utilizes its resources to generate profits.

What strategic measures can Clinigen Group take to improve ROA?

To improve ROA, Clinigen Group can take measures such as cost savings, revenue growth, optimizing asset structure, and diversifying its business activities. It is important for the company to conduct a thorough review of its financial situation to determine the best strategic measures to improve ROA.

How much dividend does Clinigen Group pay?

Over the past 12 months, Clinigen Group paid a dividend of 0.08 GBP . This corresponds to a dividend yield of about 0.82 %. For the coming 12 months, Clinigen Group is expected to pay a dividend of 0.54 GBP.

What is the dividend yield of Clinigen Group?

The current dividend yield of Clinigen Group is 0.82 %.

When does Clinigen Group pay dividends?

Clinigen Group pays a quarterly dividend. This is distributed in the months of April, December, April, January.

How secure is the dividend of Clinigen Group?

Clinigen Group paid dividends every year for the past 14 years.

What is the dividend of Clinigen Group?

For the upcoming 12 months, dividends amounting to 0.54 GBP are expected. This corresponds to a dividend yield of 5.87 %.

In which sector is Clinigen Group located?

Clinigen Group is assigned to the 'Health' sector.

Wann musste ich die Aktien von Clinigen Group kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Clinigen Group from 1/4/2022 amounting to 0.055 GBP, you needed to have the stock in your portfolio before the ex-date on 12/2/2021.

When did Clinigen Group pay the last dividend?

The last dividend was paid out on 1/4/2022.

What was the dividend of Clinigen Group in the year 2023?

In the year 2023, Clinigen Group distributed 0.514 GBP as dividends.

In which currency does Clinigen Group pay out the dividend?

The dividends of Clinigen Group are distributed in GBP.